In this webinar, expert faculty will set the stage by taking a deep dive into MF pathophysiology explaining the disease-modifying potential of novel therapies and how expanded treatment goals will help achieve deeper clinical and molecular responses.

At the end of this session, learners can give examples of environmental interventions to reduce paranoia, recommend medicines most helpful to reduce behavioral symptoms of dementia and criticize a treatment plan to optimize medication use.

At the end of this session, learners can describe common sleep disorders affecting older adults, determine treatment options for sleep problems facing patients with dementia, and infer the benefit of sleep promotion on healthy aging.

Recent understanding of multiple sclerosis (MS) has increasingly emphasized the impact of silent progression on disability accumulation and long-term outcomes.

Chronic spontaneous urticaria (CSU) has a significant impact on quality of life.Tune in to this live national webinar where leading experts will discuss these updates and answer your most pressing questions about the latest advances in CSU treatment.

At the end of this session, learners can understand the benefits of person-centered care in long term care, compare different management approaches and critique a person-centered plan to improve the quality of live.

Don’t miss this grand rounds webinar on HRS-AKI—a high-stakes diagnosis in advanced liver disease. Learn key clinical pearls, real-world cases, and the latest evidence to guide treatment decisions. Ideal for the full interprofessional care team.

At the end of this session, learners can understand how autonomy may be restricted in institutional living, predict situations in which aging in place is most appropriate, and plan for conversations about transition to institutional living.

At the end of this session, learners can compare care processes and outcomes of nursing home vs assisted living, compare caregiver burden between nursing home and assisted living, and explain cost structures.

Join us for a dynamic multidisciplinary discussion featuring an expert breast oncologist and pathologist who will share real-world challenges in HER2 testing and interpretation identified through a new nationwide survey of pathologists.